It has been demonstrated that ALD (Wrzosek et al., 2021), metabolic syndrome (Natividad et al., 2018; Hendrikx et al., 2019), and inflammatory bowel disease (Lamas et al., 2016) can all be improved by AhR activation. This evidence concerns the gene AHR and inflammatory bowel disease.